Hepion Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (HEPA) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2019 to Q2 2023

Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
HEPA on Nasdaq
Shares outstanding
11,764,939
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Hepion Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (HEPA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Anson Funds Management LP 4.9% -50% 576,482 -3.2% Anson Funds Management LP 30 Jun 2025

Institutional Holders of Hepion Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (HEPA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2023 Q2 0 $0 -$5,551,235 0
2023 Q1 7,148,482 $5,551,251 +$48,549 $0.78 23
2022 Q4 7,040,356 $2,114,166 -$3,311 $0.30 23
2022 Q3 7,141,890 $3,607,518 -$217,866 $0.50 22
2022 Q2 7,241,009 $4,144,000 -$39,245 $0.57 23
2022 Q1 0 $0 -$243,997 $0.07 0
2021 Q4 7,896,337 $8,997,101 -$9,819 $1.14 38
2021 Q3 7,744,047 $11,847,543 -$4,971,504 $1.53 32
2021 Q2 10,760,735 $21,279,439 +$5,566,720 $1.98 42
2021 Q1 7,960,205 $14,643,018 +$3,890,842 $1.84 37
2020 Q4 5,462,496 $11,963,000 +$9,168,079 $2.19 27
2020 Q3 267,804 $832,000 +$409,973 $3.10 13
2020 Q2 140,957 $403,000 -$184,871 $2.87 5
2020 Q1 207,666 $367,000 -$226,080 $1.76 5
2019 Q4 178,564 $955,720 +$514,691 $5.36 10
2019 Q3 155,684 $377,000 +$377,000 $2.43 4